- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 30, 2026 | 287.44M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 288M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 289M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $175M |
| Capex | Q1 2026 · Mar 31, 2025 | $259M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$718M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$538M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $6.25B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $5.43B |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $483M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $506M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $723M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $801M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $902M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $3B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $3.23B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $7.36B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $6.78B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $15.3B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $14.81B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $7.65B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $7.22B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $18.47B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $18.21B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.86 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.40 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.86 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.40 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $668M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $650M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$249M |
| Net Income | Q1 2026 · Mar 31, 2025 | $115M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $3.19B |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $3.51B |
| Revenue | Q1 2026 · Mar 31, 2026 | $3.88B |
| Revenue | Q1 2026 · Mar 31, 2025 | $4.25B |